PLOS One journal asks researchers for release of PACE trial data

The PACE trial researchers published an article in PLOS One in 2012, a journal that requires authors to allow other researchers access to their data.

PLOS ONE notice: Update on follow up, 7 Mar 2016

PLOS ONE is actively following up on requests for the data from this study and we are writing to provide an update on the current status.

The journal policy that applies to this article requires authors to share the data underlying the study upon request, provided that the release of the data does not compromise the confidentiality of participants in human-subjects research. The data policy that was in effect at the time of the publication of the article did not require the release of the data upon publication or a statement on how the data would be made available.

We have now carefully assessed the study and sought advice from two editorial board members, who have provided guidance on the data necessary to replicate the cost-effectiveness analyses reported in the article, and thus we have established which data we would expect the authors to share in the context of the analyses presented in this PLOS ONE article.

We have contacted the authors to request the release of the data, which include individual patient-level data underlying tables in the article. Our follow-up is ongoing as we engage with the authors and assess requirements to ensure that the confidentiality of patient data collected as part of the clinical trial is not compromised.

Prof James Coyne was one of the people who requested data in line with the PLOS One policy: Update: PLOS One affirms my (and anyone else’s) right to PACE data published there, 7 March 2016

Posted in News | Tagged , , , | Comments Off on PLOS One journal asks researchers for release of PACE trial data

Fatigue relating mechanism in Sjögren’s syndrome

Research abstract:

OBJECTIVE: Chronic fatigue is a common, disabling and poorly understood phenomenon. Recent studies indicate that epigenetic mechanisms may be involved in the expression of fatigue, a prominent feature of primary SS (pSS). The aim of this study was to investigate whether DNA methylation profiles of whole blood are associated with fatigue in patients with pSS.

METHODS: Forty-eight pSS patients with high (n = 24) or low (n = 24) fatigue as measured by a visual analogue scale were included.  Genome-wide DNA methylation was investigated using the Illumina  HumanMethylation450 BeadChip array. After quality control, a total of  383 358 Cytosine-phosphate-Guanine (CpG) sites remained for further analysis. Age, sex and differential cell count estimates were included as covariates in the association model. A false discovery rate-corrected P < 0.05 was considered significant, and a cut-off of 3% average difference in methylation levels between high- and low-fatigue patients was applied.

RESULTS: A total of 251 differentially methylated CpG sites were associated with fatigue. The CpG site with the most pronounced hypomethylation in pSS high fatigue annotated to the SBF2-antisense  RNA1 gene. The most distinct hypermethylation was observed at a CpG site annotated to the lymphotoxin alpha gene. Functional pathway analysis of genes with differently methylated CpG sites in subjects with high vs low fatigue revealed enrichment in several pathways associated with innate and adaptive immunity.

CONCLUSION: Some genes involved in regulation of the immune system and in inflammation are differently methylated in pSS patients with high vs low fatigue. These findings point to functional networks that may underlie fatigue. Epigenetic changes could constitute a fatigue-regulating mechanism in pSS.

Epigenome-wide DNA methylation patterns associated with fatigue in primary Sjögren’s syndrome, by Brække Norheim K, Imgenberg-Kreuz J, Jonsdottir K, Janssen EA, Syvänen AC, Sandling JK, Nordmark G, Omdal R. in Rheumatology (Oxford). 2016 Mar 10. pii: kew008. [Epub ahead of print]

Posted in News | Tagged , , | Comments Off on Fatigue relating mechanism in Sjögren’s syndrome

The role of lactate in ME/CFS & FM

Cort Johnson asks: Lactate – Is it Everywhere in Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS)?, 1 March 2016

Lactate (L-lactate) is an organic compound produced during anaerobic energy metabolism.  It’s constantly being formed – even when we are at rest – but is formed in higher quantities when ATP levels are low and anaerobic energy metabolism is high. Several forms of lactate are also produced by anaerobic bacteria in the gut.

Do lactate levels suggest anaerobic issues are widespread in ME/CFS and/or FM

Lactate is not bad – it actually reduces muscle fatigue – but the presence of high levels of lactate (lactic acid) signal that the anaerobic energy production process – which produces toxic metabolites that cause pain and fatigue – is in full bore.

Lactic acidosis is a state of low pH accompanied by high lactate levels. It most commonly occurs in its temporary form after excessive exercise but is found in a more permanent form in people with illnesses which produce low oxygen levels (hypoxia/hypoperfusion) including heart or lung disease, sepsis, severe physical trauma, shock, Vit B deficiency, or interestingly enough, decreased blood volume.  Symptoms include a burning feeling in the muscles, muscle weakness, rapid breathing, nausea and vomiting.

The question this blog asks is whether the processes that produce lactate/lactic acid levels could be causing pain, fatigue, cognitive and other symptoms in fibromyalgia and/or chronic fatigue syndrome.

First a look at the gut.

The Gut

D-lactic acidosis is a different form of lactic acidosis caused by the production of D-lactate by bacteria in the gut. Two forms of lactate are produced in the gut. L-lactate in the gut is considered benign but the D-lactate hypothesis posits that D-lactate  contributes to leaky gut problems. It proposes that once D-lactate gets into the blood it can push its way through the blood-brain barrier into the brain where it can cause neurological symptoms including feelings of panic, hyperventilation, delirium, ataxia and slurred speech.

Sleep Sci. 2015 Nov;8(3):124-33. doi: 10.1016/j.slsci.2015.10.001. Epub 2015 Oct 23.Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study. Jackson ML1, Butt H2, Ball M1, Lewis DP3, Bruck D1.

Reducing the levels of streptococcus bacteria in some ME/CFS patients resulted in improved sleep and vigor.

This study reported on the effects of using an antibiotic to reduce Streptococcus bacteria levels in 21 ME/CFS patients. Prior tests indicated that these patients  – out of about 75 – had increased  Streptococcus and/or  Enterococcus bacteria.  Streptococcus spp. tend to produce lactic acid, including the D-lactic form which has been associated with increased gut permeability.

After the 21 ME/CFS patients were given an antibiotic, erythromycin,  to reduce the levels of lactic-acid producing bacteria in the gut, their sleep patterns were measured using an actigraph.  Fecal samples were taken after the antibiotic.

Of the 21 ME/CFS with increased bacterial levels, tests indicated significant declines in Streptococcus spp. in a third.  The patients with reduced Streptococcus spp. levels slept about 45 minutes longer each day and reported improved vigor. It was expected, given the results of other studies, that mood measures, in particular, anxiety might improve but that did not happen.

Antibiotic treatment alone was not sufficient to significantly alter the Streptococcus levels in the other ME/CFS patients, and increased sleep times or vigor were not seen in these patients.

Erythromycin – a broad spectrum antibiotic – also reduced Lactobacillus and Bifidobacterium levels in some patients – possibly putting their flora further out of balance.

The authors believed that the central finding of the study – that antibiotic treatments can reduce Streptococcus bacterial levels and improve sleep and vigor in some ME/CFS patients – supported the D-lactate hypothesis.  (They did not directly measure lactate levels in he blood or urine). Antibiotic treatment was not effective in lowering Streptococcus levels in most patients, however, and it may disrupt the flora of other bacterial species, including, presumably, some beneficial ones.

Several factors prevented the study from being definitive. It was small and because it was an open-label study, it was impossible to disentangle placebo effects from the effects of the antibiotic. Actigraphy is also unable to measure restorative vs non-restorative sleep.

(Antibiotics are not the only way to reduce levels of D-lactate producing bacteria in the gut.   Galland reports a case of a man with short bowel syndrome and D-lactic acidosis for whom antibiotics and dietary restrictions failed. The use of two probiotics, Bifidobacterium breve Yakult and Lactobacillus casei Shirota and the prebiotic galacto-oligosaccharide worked by limiting the growth of D-lactate producing bacteria.)

The Brain

In fact several studies do suggest lactate may be causing problems in chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM).  Sheedy’s 2009 study found that two species (E. faecalis and S. sanguinis) found in ME/CFS patients guts were high D-lactic acid producers.

Shungu believes the increased lactate levels he has twice found in the brains of ME/CFS patients may result from reduced oxygen levels. He believes increased oxidative stress may release substances called isoprostanes which restrict the blood vessels in the brain. Those constricted blood vessels result in low oxygen levels (hypoxia), anaerobic energy production and the release of lactate.

In a small study Baraniuk subsequently tied increased brain lactate levels in Gulf War Syndrome to reduced cognition.  A subset of GWS patients with increased brain lactate levels prior to exercise demonstrated significantly reduced cognition after exercise. Baraniuk attributed the cognitive decline to the brains inability to utilize the lactate produced by the muscles during exercise.  The inability to use the energy resource that lactate presented resulted in the brain using anaerobic metabolism to try and meet its needs.

Muscles: Fibromyalgia

Significantly higher elevations of lactate have been found in the trapezius muscle of fibromyalgia patients and in women with chronic widespread pain – a condition similar to FM.

While many lactate studies in FM have not been done some studies suggest that the conditions for increased lactate production such as low muscle oxygen levels (hypoxia) may be present.

Increased lactate levels have been found in the trapezius muscles of FM patients

Reduced oxygen intake during exercise was recently associated with increased pain in FM. Hypoxic conditions in the skin above tender points are present. Reduced capillary density, altered microcirculation and decreased muscle blood flows could help explain that finding.

Because muscle ischemia/hypoxia (low oxygen conditions) are associated with increased pain, it’s been suggested that they could be driving the central sensitization found in FM. (Staud points out that a more acidic mileu in the muscles – possibly produced by low oxygen conditions in FM – primes the pain receptors in the muscles to act up.)

EEG studies suggest the muscles in FM have trouble relaxing causing them to stay in a more contracted state – a state that can be associated with hypoxia and causes increased pain sensitivity. Another study suggested that deficient activation of the muscle units could be causing fatigue and leading to pain.

Mitochondrial problems are another possible cause of the increased lactate found in the muscles. Enlarged mitochondria, structural muscle abnormalities and reduced numbers of mitochondria all suggested “increased muscle stress” was present.  Biopsies of the trapezius muscle in FM have shown signs of mitochondrial disturbances.

Muscles: Chronic Fatigue Syndrome (ME/CFS)

A computer model of exercise intolerance caused by mitochondrial dysfunction in ME/CFS predicts increased lactate production in the muscles will occur.

Mitochondrial Depletion Could Underlie the Energy Problems in Chronic Fatigue Syndrome

Lane found increased muscle lactate production in ME/CFS three times. The third time he linked it to the presence of enteroviral RNA in the muscles.

Newton has shown that people with ME/CFS produce up to 20 times more acid and have more difficulty removing acids from their muscles during exercise. In a rather remarkable study Newton linked muscle pH issues in ME/CFS with hyperventilation and reduced oxygenation of the brain. Nijs’s finding that recovery of muscle function after exercise was associated with improved cognition suggested that muscle problems and brain functioning may be linked.

Numerous other studies, of course, have found problems with energy metabolism during exercise in chronic fatigue syndrome.

The Lactate Question

The lactate question ends up not being a question about lactate per se, but about whether widespread problems with anaerobic energy production are found in the brains, muscles and/or guts of FM and ME/CFS patients.  Multiple studies in both diseases suggest that that they may. High lactate or similar problems have been found in multiple areas ME/CFS and in the muscles of FM patients.

woman-tired-after-exerciseThe gut is the newest entry into the lactate question. Thus far the evidence that anaerobic bacteria are producing a form of lactate called D-lactate which causes cognitive, sleep, fatigue and other issues in ME/CFS is not particularly strong but it is tending in that direction.

Numerous studies on the other hand suggest that widespread low oxygen conditions could be causing a variety of problems including reduced energy production, muscle issues, increased pain and fatigue and cognitive problems in ME/CFS and FM.

Posted in News | Tagged , , , , , , , | Comments Off on The role of lactate in ME/CFS & FM

Self-management helpful for idiopathic chronic fatigue

Research abstract:

OBJECTIVE: To determine the efficacy of a cognitive-behavioral intervention for patients meeting U.S. Centers for Disease Control and Prevention (CDC) criteria for idiopathic chronic fatigue (ICF). ICF is thought to be a less severe disorder than chronic fatigue syndrome (CFS). The intervention consisted of a booklet with self-instructions combined with e-mail contact with a therapist.

METHOD: Randomized controlled trial conducted at an outpatient facility.  All patients suffered from severe and persistent fatigue with moderate impairment levels or fewer than 4 additional symptoms. Patients were randomly allocated to either guided self-instruction or a wait-list control group. Primary outcome measures were fatigue severity assessed with the Checklist Individual Strength and level of overall impairment assessed with the Sickness Impact Profile. Outcome measures were assessed prior to randomization and following treatment or  wait-list control group.

RESULTS: One hundred patients were randomly allocated to the intervention or a wait-list control group and 95 completed second assessment. An intention-to-treat analysis showed significant treatment effects for fatigue severity (-8.98, 95% confidence interval [CI] [-13.99, -3.97], Cohen’s d = 0.68, p < .001) and for overall impairment (-317.19, 95% CI [-481.70, -152.68], Cohen’s d = 0.53, p < .01) in favor of the intervention. The number of additional symptoms and overall impairment at baseline did not moderate post-treatment fatigue severity. Baseline  overall impairment moderated post-treatment impairment.

CONCLUSIONS: Patients with ICF can be treated effectively with a minimal intervention. This is relevant as ICF is more prevalent than CFS and treatment capacity is limited.

The Efficacy of Guided Self-instruction for Patients With Idiopathic Chronic Fatigue: A Randomized Controlled Trial, by A Janse, JF Wiborg, G Bleijenberg, M Tummers, H Knoop in J Consult Clin Psychol. 2016 Mar 7 [Epub ahead of print]

Comment by Tom Kindlon, 28 Feb 2017:

A major limitation was not mentioned: no objective outcome measures were used
I was amazed to read the long (906-word) limitations section and find no mention of the limitation that the results rely solely on subjective outcome measures[1].

The most obvious outcome measure to use would have been actometers which measure activity levels objectively. The equipment was available to the researchers as it was used at baseline [“Physical activity was assessed with an actometer, a motion-sensing device worn at the ankle for 14 days”].

The importance of the use of such a measure can be seen in the results of an earlier study using the the same or very similar intervention on people with chronic fatigue syndrome[2]. That study involved two of the current research team with one of them being its corresponding author. That paper reported improvements in the intervention group on the CIS fatigue severity, SIP8 total score and SF–36 physical functional questionnaires (which were also used in the current study). Subsequently to that, data from the actometers were reported in a paper co-authored by three of the current team[3]. Both the intervention group and the control group had the same change in activity, 4.3 units, during the trial. The intervention group finished at a mean of 67.8 units, significantly less than the actometer scores for healthy controls of 91.

Numerous response biases could be at play in this nonblinded study with such interventions causing participants to report improvements without their objectively-measured levels of functioning having improved.

If actometers were used during or after the current study, it is important that the researchers should now release such data, rather than delay for years as they have done with some trials before[3].

References:

1 Janse A, Wiborg JF, Bleijenberg G, Tummers M, Knoop H. The efficacy of guided self-instruction for patients with idiopathic chronic fatigue: A randomized controlled trial. J Consult Clin Psychol. 2016 May;84(5):377-88.

2 Knoop H, van der Meer JW, Bleijenberg G. Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial. Br J Psychiatry. 2008 Oct;193(4):340-1.

3 Wiborg JF, Knoop H, Stulemeijer M, Prins JB, Bleijenberg G. How does cognitive behaviour therapy reduce fatigue in patients with chronic fatigue syndrome? The role of physical activity. Psychol Med. 2010 Aug;40(8):1281-7.

Posted in News | Tagged , , , , | Comments Off on Self-management helpful for idiopathic chronic fatigue

Can aluminium additives to vaccines cause fatigue and cognitive dysfunction?

Research abstract:

Aluminum oxyhydroxide (Alhydrogel®) is a nano-crystalline compound forming aggregates that has been introduced in vaccine for its immunologic adjuvant effect in 1926. It is the most commonly used adjuvant in human and veterinary vaccines but mechanisms by which it stimulates immune responses remain ill-defined.

Although generally well tolerated on the short term, it has been suspected to occasionally cause delayed neurologic problems in susceptible individuals. In particular, the long-term persistence of aluminic granuloma also termed macrophagic myofasciitis is associated with chronic arthromyalgias and fatigue and cognitive dysfunction.

Safety concerns largely depend on the long biopersistence time inherent to this adjuvant, which may be related to its quick withdrawal from the interstitial fluid by avid cellular uptake; and the capacity of adjuvant particles to migrate and slowly accumulate in lymphoid organs and the brain, a phenomenon documented in animal models and resulting from MCP1/CCL2-dependant translocation of adjuvant-loaded monocyte-lineage cells (Trojan horse phenomenon).

These novel insights strongly suggest that serious re-evaluation of long-term aluminum adjuvant phamacokinetics and safety should be carried out.

Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease, by Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ. in Morphologie. 2016 Mar 2. pii: S1286-0115(16)00025-4. [Epub ahead of print]

Posted in News | Tagged , , , | Comments Off on Can aluminium additives to vaccines cause fatigue and cognitive dysfunction?

Guidance for community nurses on nutrition advice for IBS, CFS etc.

Article abstract:

This article describes the conclusions of an expert panel that discussed four case studies; these were examples of patients typically encountered by nurses working in the community.

The panel considered the nutritional and lifestyle advice that could be given by nurses relating to conditions such as irritable bowel syndrome (IBS), depression, chronic fatigue syndrome, vulnerability to common infections, elderly care, recurrent urinary tract infection, antibiotic use, and risk of type 2 diabetes.

A general conclusion was the importance of motivational interviewing techniques in achieving full understanding of patients’ concerns and to determine the best health strategy.

As well as specific guidance appropriate for each disorder, a range of information sources for both health professionals and patients are listed in the paper. The panel noted that, although general nutritional advice can be given by nurses working at GP surgeries and in the community, patients should always be referred to registered dietitians or nutritionists if significant dietary changes are considered.

Nutritional advice for community patients: Insights from a panel discussion, by Linda V Thomas, Gill Jenkins, Julie Belton, Suzie Clements, Ciara Jacob, Naomi Johnson, Deirdre Joy, Jennifer Low, Eileen Munson, Jessica Sheppard in British Journal of Community Nursing 21:3 March 4, 2016

 

Posted in News | Tagged , , , | Comments Off on Guidance for community nurses on nutrition advice for IBS, CFS etc.

The virtual lives of people with ME/CFS in Second Life

Research abstract:

Using case studies, the author analyzes how people with myalgic encephalomyelitis/ chronic fatigue syndrome construct their  subjectivities in the multi-user virtual environment Second Life.

The findings of the study reveal people’s anxieties about identity and belonging, especially where interlocking disadvantages such as economic class, gender, mental health, disability, and chronic illness influence who is accepted as a member of the support groups held in-world.

Virtual selves, virtual communities: Self-narration and social relations in multi-user virtual environments, by Stephanie Butler in Auto/Biography Studies, 1 March 2016

Posted in News | Tagged , , , | Comments Off on The virtual lives of people with ME/CFS in Second Life

US NIH plans in-depth ME/CFS study

Simon McGrath reports on: the most in-depth, comprehensive and innovative ME/CFS studies ever proposed: it’s the first fruit of Director Dr Francis Collins’s ‘new start’ for ME/CFS at the US National Institutes of Health (NIH).

Nath2011

Dr Nath, who is Chief of the Section of Infections of the Nervous System at the NIH’s National Institute of Neurological Diseases and Stroke, will lead the study: and he believes the immune system is where the action is.

Dr Nath said, “Our hypothesis is that post-infectious ME/CFS is triggered by a viral illness that results in immune-mediated brain dysfunction”.

The NIH is taking a very thorough approach to investigating immune (and other) problems. Although it’s relatively small, with 40 patients and 60 controls, the study is extraordinarily comprehensive, with two more studies due to build on its results, culminating, it’s planned, in trials of immunomodulatory agents.

Study highlights

The study will take an astonishingly in-depth look at the immune system, both via the blood and spinal fluid. On the basis of the initial findings, the NIH will decide where to target even more sophisticated tests.

The researchers will use a wide range of measures: thinking tests, metabolic tests that even measure how much energy patients burn as they sleep, autonomic function tests, and self-reported fatigue alongside activity measurement.

Best of all, the study will look at how most of these measures are changed by exercise, focusing on the core feature of ME/CFS. And they will use two types of technology to probe what happens in the brain when patients are hit by exercise.

The most ambitious part of the study will use cutting-edge technology to try to reproduce in the laboratory the clinical or biological abnormalities seen in patients. It could dramatically speed up understanding of the illness and the development of treatments.
The hope is that this intensive approach will crack open the illness so researchers can see more clearly what’s inside – providing clues that could help reveal the mechanism of the illness, and lead to treatments.

Read full article: Extraordinary NIH ME/CFS study may be most comprehensive and in-depth ever

 

Posted in News | Tagged , , , | Comments Off on US NIH plans in-depth ME/CFS study

Canadian evidence-based ME/CFS diagnosis and management

Article abstract:

This review was written from the viewpoint of the treating clinician to educate health care professionals and the public about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It includes: the clinical definition of ME/CFS with emphasis on how to diagnose ME/CFS; the etiology, pathophysiology, management approach, long-term prognosis and economic cost of ME/CFS.

After reading this review, you will be better able to diagnose and treat your patients with ME/CFS using the tools and information provided. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, chronic medical condition characterized by symptom clusters that include: pathological fatigue and malaise that is worse after exertion, cognitive dysfunction, immune dysfunction, unrefreshing sleep, pain, autonomic dysfunction, neuroendocrine and immune symptoms.

ME/CFS is common, often severely disabling and costly. The Institute of Medicine (IOM) reviewed the ME/CFS literature and estimates that between 836,000 and 2.5 million Americans have ME/CFS at a cost of between 17 and 24 billion dollars annually in the US.

The IOM suggested a new name for ME/CFS and called it Systemic Exertion Intolerance Disease (SEID). SEID’s diagnostic criteria are less specific and do not exclude psychiatric disorders in the criteria. The 2010 Canadian Community Health Survey discovered that 29% of patients with ME/CFS had unmet health care needs and 20% had food insecurity – lack of access to sufficient healthy foods.

ME/CFS can be severely disabling and cause patients to be bedridden. Yet most patients (80%) struggle to get a diagnosis because doctors have not been taught how to diagnose or treat ME/CFS in medical schools or in their post-graduate educational training. Consequently, the patients with ME/CFS suffer.

They are not diagnosed with ME/CFS and are not treated accordingly. Instead of compassionate care from their doctors, they are often ridiculed by the very people from whom they seek help.

The precise etiology of ME/CFS remains unknown, but recent advances and research discoveries are beginning to shed light on the enigma of this disease including the following contributors: infectious, genetic, immune, cognitive including sleep, metabolic and biochemical abnormalities.

Management of patients with ME/CFS is supportive symptomatic treatment with a patient centered care approach that begins with the symptoms that are most troublesome for the patient. Pacing of activities with strategic rest periods is, in our opinion, the most important coping strategy patients can learn to better manage their illness and stop their post-exertional fatigue and malaise. Pacing allows patients to regain the ability to plan activities and begin to make slow incremental improvements in functionality.

Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians, by AC Bested, LM Marshall in Reviews on Environmental Health, 2015 Dec 1;30(4):223-49

Posted in News | Tagged , , , , , | Comments Off on Canadian evidence-based ME/CFS diagnosis and management

Dr Bell discusses inappropriate diagnosis of Munchausen’s Syndrome by Proxy in children with ME/CFS

Article extract:

Munchausen’s Syndrome by Proxy (MSBP) is a form of abuse in which a caregiver  deliberately produces or feigns illness in a person under his or her care. A rare disorder, it most frequently consists of poisoning of an infant by an adult caregiver. A related condition is ‘factitious disorder by proxy’, also referred to as ‘pediatric condition falsification’. The Diagnostic and Statistical Manual of Mental Disorders, requires the intentional production or feigning of physical or psychological signs or symptoms for the diagnosis of factitious disorder. It also suggests that the motivation for the behavior is to assume the sick role, and that there be no external incentives for the behavior such as economic gain. “The diagnosis of FD can only be confirmed if observation of symptom-producing behavior occurs or is admitted.”

Thus the essential feature of both MSBP and factitious disorder is the intentional and
conscious imitation or production of illness. While there have been legitimate controversies concerning ME/CFS, the intentional or conscious attempt to feign the illness is close to impossible because of the complexity of the symptoms. Very few medical providers are even aware of the ME/CFS symptoms involving sleep, orthostatic intolerance, post-exertional malaise and sensory sensitivities. If pediatricians were better aware of ME/CFS, MSBP or factitious disorder would not enter the conversation…

One important question remains however: can an overly sympathetic parent cause activity limitation in an adolescent? While this has never been answered scientifically, it is highly unlikely. Behavioral problems caused by family dysfunction usually result in hyperactivity
not hypersomnolence. An overindulged and undisciplined child is clearly not characterized by activity limitation. And in the era of rheumatic fever, where strict bed rest was prescribed as a treatment, it was invariably unsuccessful…

Conclusion: The lack of training and awareness of pediatricians in the subject of ME/CFS has led to the inappropriate diagnosis of MSBP and factitious disorder, both of which can result in placement of the child or adolescent in either psychiatric hospitalization or foster care. There is ample evidence that ME/CFS is not a psychiatric condition, and the recent IOM publication has clearly stated “Seeking and receiving a diagnosis can be a frustrating process for several reasons, including skepticism of health care providers about the serious nature of ME/CFS and the misconception that it is a psychogenic illness or even a figment of the patient’s imagination… Physicians should diagnose myalgic encephalomyelitis/ chronic fatigue syndrome if diagnostic criteria are met following an appropriate history, physical examination, and medical work-up.

Munchausen’s Syndrome by Proxy, Factitious Disorders in Children and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Dr David S Bell, IACFSME, Dec 2015

Posted in News | Tagged , , , , | Comments Off on Dr Bell discusses inappropriate diagnosis of Munchausen’s Syndrome by Proxy in children with ME/CFS